肌层浸润性膀胱癌保留膀胱综合治疗专家共识

原文： 2022 年发布于中华泌尿外科杂志 43 卷第 6 期 1071-1081  浏览量：201次 原文链接

DOI： 10.1111/bju.13819

文献简介

暂无

原文网址： https://d.wanfangdata.com.cn/periodical/ChlQZXJpb2RpY2FsQ0hJTmV3UzIwMjMwNDI2Eg96aG1ud2syMDIyMDYwMDEaCGRnNmxkNG9x

非肌层浸润性膀胱癌膀胱灌注治疗专家共识(2021版)

中国膀胱癌保膀胱治疗多学科诊治协作共识

热门文献

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

 Clin Invest Med 1261
Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

 J Cancer Res Ther 39 卷第 6 期 882
吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

 PeerJ 60 卷第 5 期 840
Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

 Int J Nurs Pract 13 卷第 4 期 784
Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

 Bmc Urology 728
Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

 Oncotarget 706
Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

 Eur J Nutr 11 卷第 2 期 696
[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

 Front Endocrinol (Lausanne) 13 卷第 11 期 688
膀胱癌标本规范化处理和病理诊断共识

 中华病理学杂志 49卷第4期 675
Clinical Outcomes after Intravesical Bacillus Calmette–Guérin for the Highest-risk Non-muscle-invasive Bladder Cancer Newly Defined in the Japanese Urological Association Guidelines 2019

 International Journal of Urology 671

肌层浸润性膀胱癌保留膀胱综合治疗专家共识

原文： 2022 年发布于中华泌尿外科杂志 43 卷第 6 期 1071-1081  浏览量：201次 原文链接

文献简介

上一篇

非肌层浸润性膀胱癌膀胱灌注治疗专家共识(2021版)

下一篇

中国膀胱癌保膀胱治疗多学科诊治协作共识

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

膀胱癌标本规范化处理和病理诊断共识

Clinical Outcomes after Intravesical Bacillus Calmette–Guérin for the Highest-risk Non-muscle-invasive Bladder Cancer Newly Defined in the Japanese Urological Association Guidelines 2019

肌层浸润性膀胱癌保留膀胱综合治疗专家共识

原文： 2022 年 发布于 中华泌尿外科杂志 43 卷 第 6 期 1071-1081  浏览量：201次 原文链接

文献简介

上一篇

下一篇

原文： 2022 年发布于中华泌尿外科杂志 43 卷第 6 期 1071-1081  浏览量：201次 原文链接